Test 008 for Riley Tanaka

Request

Create a concise, claim-safe outcome memo for the Q4 Pricing Path Clarity Test. State whether the predeclared path-quality threshold and each guardrail passed, the rollout the result supports, the boundaries that remain unchanged, and the commercial conclusions the result does not establish.

Required memory

Fact 157

The Q4 Pricing Path Clarity Test cleared the predeclared path-quality threshold and both guardrails.

Source evidence (1)

003470Nov 19, 2025 / 09:18 UTC-06:00

Owen has certified the completed four-cohort Q4 Pricing Path Clarity Test read. Across 3,286 organic pricing-page sessions, there were 1,639 control and 1,647 treatment sessions. Among Helio Start eligibility-flow starts, 38 of 344 control starts (11.0%) versus 25 of 352 treatment starts (7.1%) routed out for an existing unsupported condition, a 35.7% relative reduction. Eligible-workspace admission completion was 43.8% in control and 44.1% in treatment, and account-level support time at the 90th percentile was 71 minutes in control and 74 minutes in treatment. The direction held in all three weekly cohorts and the November 10–16 stabilization cohort, with no unrelated pricing-page layout or UI change. This clears the predeclared path-quality threshold and both guardrails. Update the existing “Q4 Pricing Path Clarity Test — design brief” with the certified denominators, result, guardrails, attribution check, and my recommendation to adopt treatment for organic traffic while leaving every admission and acquisition boundary unchanged. Make clear that this supports fewer unsupported self-serve starts and a pricing-page rollout decision—not paid-acquisition economics, pipeline impact, forecast credit, revenue lift, or a change to Helio Start eligibility—and that treatment remains non-default pending Priya’s November 25 decision.

Message 003470 in history

Fact 158

Riley Tanaka requested that the “Q4 Pricing Path Clarity Test — design brief” include Riley’s recommendation to adopt the treatment for organic traffic while leaving every admission and acquisition boundary unchanged.

Source evidence (1)

003470Nov 19, 2025 / 09:18 UTC-06:00

Owen has certified the completed four-cohort Q4 Pricing Path Clarity Test read. Across 3,286 organic pricing-page sessions, there were 1,639 control and 1,647 treatment sessions. Among Helio Start eligibility-flow starts, 38 of 344 control starts (11.0%) versus 25 of 352 treatment starts (7.1%) routed out for an existing unsupported condition, a 35.7% relative reduction. Eligible-workspace admission completion was 43.8% in control and 44.1% in treatment, and account-level support time at the 90th percentile was 71 minutes in control and 74 minutes in treatment. The direction held in all three weekly cohorts and the November 10–16 stabilization cohort, with no unrelated pricing-page layout or UI change. This clears the predeclared path-quality threshold and both guardrails. Update the existing “Q4 Pricing Path Clarity Test — design brief” with the certified denominators, result, guardrails, attribution check, and my recommendation to adopt treatment for organic traffic while leaving every admission and acquisition boundary unchanged. Make clear that this supports fewer unsupported self-serve starts and a pricing-page rollout decision—not paid-acquisition economics, pipeline impact, forecast credit, revenue lift, or a change to Helio Start eligibility—and that treatment remains non-default pending Priya’s November 25 decision.

Message 003470 in history

Fact 159

Riley Tanaka requested that the “Q4 Pricing Path Clarity Test — design brief” clarify that the result supports fewer unsupported self-serve starts and a pricing-page rollout decision, but does not establish paid-acquisition economics, pipeline impact, forecast credit, revenue lift, or any change to Helio Start eligibility.

Source evidence (1)

003470Nov 19, 2025 / 09:18 UTC-06:00

Owen has certified the completed four-cohort Q4 Pricing Path Clarity Test read. Across 3,286 organic pricing-page sessions, there were 1,639 control and 1,647 treatment sessions. Among Helio Start eligibility-flow starts, 38 of 344 control starts (11.0%) versus 25 of 352 treatment starts (7.1%) routed out for an existing unsupported condition, a 35.7% relative reduction. Eligible-workspace admission completion was 43.8% in control and 44.1% in treatment, and account-level support time at the 90th percentile was 71 minutes in control and 74 minutes in treatment. The direction held in all three weekly cohorts and the November 10–16 stabilization cohort, with no unrelated pricing-page layout or UI change. This clears the predeclared path-quality threshold and both guardrails. Update the existing “Q4 Pricing Path Clarity Test — design brief” with the certified denominators, result, guardrails, attribution check, and my recommendation to adopt treatment for organic traffic while leaving every admission and acquisition boundary unchanged. Make clear that this supports fewer unsupported self-serve starts and a pricing-page rollout decision—not paid-acquisition economics, pipeline impact, forecast credit, revenue lift, or a change to Helio Start eligibility—and that treatment remains non-default pending Priya’s November 25 decision.

Message 003470 in history

Expected tool calls

create_doc

Grading

1. field_equals / create_doc

{
  "type": "field_equals",
  "tool": "create_doc",
  "action_id": "create_claim_safe_memo",
  "path": "result.ok",
  "value": true,
  "check_id": "riley_008_00"
}

2. field_llm_judge / create_doc

{
  "type": "field_llm_judge",
  "tool": "create_doc",
  "action_id": "create_claim_safe_memo",
  "path": "args",
  "criterion": "The memo states that the stabilized test result cleared the predeclared path-quality threshold and both guardrails and supports adopting the treatment for organic pricing-page traffic, framing the measured benefit as fewer unsupported self-serve starts or improved path quality rather than commercial performance.\n\nThe memo clearly states that admission and acquisition boundaries remain unchanged and does not imply that the experiment broadened admission rules or acquisition access.\n\nThe memo explicitly says the result does not establish paid-acquisition economics, pipeline impact, forecast credit, revenue lift, or any change to Helio Start eligibility.",
  "check_id": "riley_008_01"
}

Complete grading specification

{
  "type": "tool_trace",
  "config": {
    "check_version": 2,
    "today": "2028-01-01",
    "semantic_judge_version": 2,
    "assertions": [
      {
        "type": "field_equals",
        "tool": "create_doc",
        "action_id": "create_claim_safe_memo",
        "path": "result.ok",
        "value": true,
        "check_id": "riley_008_00"
      },
      {
        "type": "field_llm_judge",
        "tool": "create_doc",
        "action_id": "create_claim_safe_memo",
        "path": "args",
        "criterion": "The memo states that the stabilized test result cleared the predeclared path-quality threshold and both guardrails and supports adopting the treatment for organic pricing-page traffic, framing the measured benefit as fewer unsupported self-serve starts or improved path quality rather than commercial performance.\n\nThe memo clearly states that admission and acquisition boundaries remain unchanged and does not imply that the experiment broadened admission rules or acquisition access.\n\nThe memo explicitly says the result does not establish paid-acquisition economics, pipeline impact, forecast credit, revenue lift, or any change to Helio Start eligibility.",
        "check_id": "riley_008_01"
      }
    ]
  }
}